Circulating beta-hydroxybutyrate levels are associated with major adverse clinical events in patients with acute myocardial infarction
Event: ESC Congress 2024
Topic: ST-Elevation Myocardial Infarction (STEMI)
Session: Emerging insights in acute coronary syndrome: biomarkers, non-traditional risk factors, and clinical outcomes
